Journal article icon

Journal article

Status report of lipid-lowering trials in diabetes.

Abstract:
The prevention and treatment of coronary heart disease is a major challenge in the overall management of the patient with type 2 diabetes. Diabetic dyslipidaemia is an important risk factor and is open to therapeutic intervention. However, as yet there are no primary or secondary coronary heart disease prevention trials of lipid-lowering therapy reported in diabetic populations. In this review, on-going clinical trials of lipid-lowering therapy in specific diabetic populations will be described.
Publication status:
Published

Actions


Access Document


Journal:
Current opinion in lipidology More from this journal
Volume:
11
Issue:
6
Pages:
621-626
Publication date:
2000-12-01
DOI:
EISSN:
1473-6535
ISSN:
0957-9672
Language:
English
Keywords:
Pubs id:
pubs:49557
UUID:
uuid:6f39546b-3cdc-4cbb-8228-8071da2ecef6
Local pid:
pubs:49557
Source identifiers:
49557
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP